A one-time-only drug to treat spinal muscular atrophy (SMA) that will cost NT$49 million (US$1.58 million) will soon be covered for infants six months old and under by Taiwan's universal health insurance system.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Red alert lifted for Matai'an Creek barrier lake after one month
10/22/2025 04:03 PM - Business
Tennessee governor signs MOU, announces plan to open Taiwan office: MOFA
10/22/2025 03:13 PM - Politics
U.S. planning new rules to expedite defense tech transfers: Business group
10/22/2025 03:08 PM - Society
Taiwan imposes disease controls amid suspected ASF outbreak
10/22/2025 02:54 PM - Business
Taiwan shares close down 0.37%
10/22/2025 02:10 PM